These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
209 related items for PubMed ID: 20582308
1. Structural optimization and de novo design of dengue virus entry inhibitory peptides. Costin JM, Jenwitheesuk E, Lok SM, Hunsperger E, Conrads KA, Fontaine KA, Rees CR, Rossmann MG, Isern S, Samudrala R, Michael SF. PLoS Negl Trop Dis; 2010 Jun 22; 4(6):e721. PubMed ID: 20582308 [Abstract] [Full Text] [Related]
2. Peptide inhibitors of dengue virus and West Nile virus infectivity. Hrobowski YM, Garry RF, Michael SF. Virol J; 2005 Jun 01; 2():49. PubMed ID: 15927084 [Abstract] [Full Text] [Related]
3. Computational identification of self-inhibitory peptides from envelope proteins. Xu Y, Rahman NA, Othman R, Hu P, Huang M. Proteins; 2012 Aug 01; 80(9):2154-68. PubMed ID: 22544824 [Abstract] [Full Text] [Related]
4. In vitro analysis of synthetic peptides in blocking the entry of dengue virus. John AM, Jittmittraphap A, Chattanadee S, Alwin Prem Anand A, Shenbagarathai R, Leaungwutiwong P. Virus Res; 2019 Jan 15; 260():142-150. PubMed ID: 30508603 [Abstract] [Full Text] [Related]
5. Peptide inhibitors against dengue virus infection. Panya A, Bangphoomi K, Choowongkomon K, Yenchitsomanus PT. Chem Biol Drug Des; 2014 Aug 15; 84(2):148-57. PubMed ID: 24612829 [Abstract] [Full Text] [Related]
6. Small-molecule inhibitors of dengue-virus entry. Schmidt AG, Lee K, Yang PL, Harrison SC. PLoS Pathog; 2012 Aug 15; 8(4):e1002627. PubMed ID: 22496653 [Abstract] [Full Text] [Related]
7. Inhibition of dengue virus entry into target cells using synthetic antiviral peptides. Alhoot MA, Rathinam AK, Wang SM, Manikam R, Sekaran SD. Int J Med Sci; 2013 Aug 15; 10(6):719-29. PubMed ID: 23630436 [Abstract] [Full Text] [Related]
8. A peptide inhibitor derived from the conserved ectodomain region of DENV membrane (M) protein with activity against dengue virus infection. Panya A, Sawasdee N, Junking M, Srisawat C, Choowongkomon K, Yenchitsomanus PT. Chem Biol Drug Des; 2015 Nov 15; 86(5):1093-104. PubMed ID: 25891143 [Abstract] [Full Text] [Related]
9. Peptides P4 and P7 derived from E protein inhibit entry of dengue virus serotype 2 via interacting with β3 integrin. Cui X, Wu Y, Fan D, Gao N, Ming Y, Wang P, An J. Antiviral Res; 2018 Jul 15; 155():20-27. PubMed ID: 29709564 [Abstract] [Full Text] [Related]
10. Discovery of Immunologically Inspired Small Molecules That Target the Viral Envelope Protein. Lian W, Jang J, Potisopon S, Li PC, Rahmeh A, Wang J, Kwiatkowski NP, Gray NS, Yang PL. ACS Infect Dis; 2018 Sep 14; 4(9):1395-1406. PubMed ID: 30027735 [Abstract] [Full Text] [Related]
14. Manipulation of immunodominant dengue virus E protein epitopes reduces potential antibody-dependent enhancement. Hughes HR, Crill WD, Chang GJ. Virol J; 2012 Jun 18; 9():115. PubMed ID: 22709350 [Abstract] [Full Text] [Related]
15. De novo design approaches targeting an envelope protein pocket to identify small molecules against dengue virus. Leal ES, Adler NS, Fernández GA, Gebhard LG, Battini L, Aucar MG, Videla M, Monge ME, Hernández de Los Ríos A, Acosta Dávila JA, Morell ML, Cordo SM, García CC, Gamarnik AV, Cavasotto CN, Bollini M. Eur J Med Chem; 2019 Nov 15; 182():111628. PubMed ID: 31472473 [Abstract] [Full Text] [Related]
16. Peptide inhibitor of Japanese encephalitis virus infection targeting envelope protein domain III. Zu X, Liu Y, Wang S, Jin R, Zhou Z, Liu H, Gong R, Xiao G, Wang W. Antiviral Res; 2014 Apr 15; 104():7-14. PubMed ID: 24468276 [Abstract] [Full Text] [Related]
19. Identification of the phytobioactive Polygonum cuspidatum as an antiviral source for restricting dengue virus entry. Kuo YT, Liu CH, Li JW, Lin CJ, Jassey A, Wu HN, Perng GC, Yen MH, Lin LT. Sci Rep; 2020 Oct 02; 10(1):16378. PubMed ID: 33009425 [Abstract] [Full Text] [Related]